Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: ARF nucleotide-binding site opener (ARNO) is a guanine nucleotide-exchange factor for ADP-ribosylation factor proteins. ARF nucleotide-binding site opener also binds MyD88, and small-molecule inhibition of ARNO reduces inflammation in animal models of inflammatory arthritis and acute inflammation. However, whether genetic deletion of in mice reduces pathologic inflammation has not yet been reported. Furthermore, its role in the nasal cavity has yet to be investigated.

Objective: To generate knockout mice and to determine whether genetic loss of reduces eosinophilic inflammation in the ovalbumin (OVA) murine model of rhinitis.

Methods: knockout mice were generated and wild type and knockout littermates were subjected to the OVA-induced mouse model of rhinosinutitis. Eosinophilic inflammation was assessed through immunofluorescent quantification of EMBP eosinophils in the septal mucosa and cytokine expression was assessed by quantitative polymerase chain reaction.

Results: knockout mice are viable and fertile without any noted deficits. wild type and knockout mice subjected to the OVA-induced model of rhinitis demonstrated an average of 314.5 and 153.8 EMBP cells per mm septal tissue, respectively ( < .05). Goblet cells per mm of basal lamina were assessed via Alcian blue and there was no statistically significant difference between wild type and knockout mice. Ovalbumin-induced expression of interleukin-5 (IL-5) was significantly reduced in knockout mice ( < .05). There was no statistically significant reduction in IL-4, IL-13, or eotaxin-1 expression.

Conclusions: These data demonstrate that deletion of reduces eosinophilic inflammation and IL-5 expression in an OVA-induced model of rhinitis.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0145561320986055DOI Listing

Publication Analysis

Top Keywords

knockout mice
24
eosinophilic inflammation
16
reduces eosinophilic
12
model rhinitis
12
wild type
12
type knockout
12
deletion reduces
8
murine model
8
arf nucleotide-binding
8
nucleotide-binding site
8

Similar Publications

Voltage-gated K channels of the Kv2 family coassemble with electrically silent KvS subunits in specific subpopulations of brain neurons, forming heteromeric Kv2/KvS channels with distinct functional properties. Little is known about the composition and function of Kv2 channels in spinal cord neurons, however. Here, we show that while Kv2.

View Article and Find Full Text PDF

Aims: The clusterin (CLU) gene is genetically associated with Alzheimer's disease (AD), and CLU levels have been shown to positively correlate with regional Aβ deposition in the brain, including in arteries from cerebral amyloid angiopathy (CAA) patients. CLU has also been shown to alter the aggregation, toxicity and blood-brain barrier transport of amyloid beta (Aβ) and has therefore been suggested to play a key role in regulating the balance between Aβ deposition and clearance in both the brain and cerebral blood vessels. However, it remains unclear whether the role of clusterin in relation to Aβ deposition is protective or pathogenic.

View Article and Find Full Text PDF

Zika virus (ZIKV) is a mosquito-borne flavivirus causing a major epidemic in the Americas in 2015. Dendritic cells (DCs) are leukocytes with key antiviral functions, but their role in ZIKV infection remains under investigation. While most studies have focused on the monocyte-derived subtype of DCs, less is known about conventional dendritic cells (cDCs), essential for the orchestration of antiviral adaptive immunity.

View Article and Find Full Text PDF

Background: has the ability to adapt to variable environments by modulating metabolism. The Tricarboxylic Acid Cycle (TCA), as a core metabolic process, is critical for the environmental adaptation and infection process of . Fumarate reductase FrdA is an important enzyme in the TCA cycle, mainly catalyzing the conversion of fumarate to succinate.

View Article and Find Full Text PDF

Multiplex engineering using microRNA-mediated gene silencing in CAR T cells.

Front Immunol

September 2025

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Background: Multiplex gene-edited chimeric antigen receptor (CAR) T-cell therapies face significant challenges, including potential oncogenic risks associated with double-strand DNA breaks. Targeted microRNAs (miRNAs) may provide a safer, functional, and tunable alternative for gene silencing without the need for DNA editing.

Methods: As a proof of concept for multiplex gene silencing, we employed an optimized miRNA backbone and gene architecture to silence T-cell receptor (TCR) and major histocompatibility complex class I (MHC-I) in mesothelin-directed CAR (M5CAR) T cells.

View Article and Find Full Text PDF